Bart Kesteleyn

Also affiliated with Janssen (United States)

Pharmacology, Toxicology and PharmaceuticsBiochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “A pan-serotype antiviral to prevent and treat dengue: A journey from discovery to clinical development driven by public-private partnerships”.

A pan-serotype antiviral to prevent and treat dengue: A journey from discovery to clinical development driven by public-private partnerships

Antiviral Research(2022)10.1016/j.antiviral.2022.105495

N/A

0DataRank · unranked

18 citations

Natalia V. Voge, Bart Kesteleyn, Patrick Chaltin, Tim Jinks, Tine De Marez +5 more

Blocking NS3–NS4B interaction inhibits dengue virus in non-human primates

Nature(2023)10.1038/s41586-023-05790-6

N/A

0DataRank · unranked

129 citations

Suzanne J. F. Kaptein, Bart Kesteleyn, Jean‐François Bonfanti, Liesbeth Van Wesenbeeck, Dorothée Bardiot +39 more